Medindia LOGIN REGISTER
Medindia
Advertisement

Cellvax Expands its Preclinical Service Offers by Moving to a New Laboratory Facility With an Access to Large Animals and a Number of New Technical Plat-Forms

Thursday, April 1, 2010 Research News
Advertisement
PARIS, March 31, 2010 Cellvax is a French service companywhich provides complete in vitro & in vivo preclinical innovating servicesallowing to accelerate the drug development process for unmet needs relatedwith severe human diseases, mainly in oncology field.
Advertisement

Cellvax was created in 2001 as a French SME by a motivated andcomplementary team consisting of scientists and experts in these fields. Byoffering its know-how and its capacity of innovation, Cellvax hassuccessfully accomplished numerous in vitro and in vivo studies for differentcompanies in Europe, Israel and in the world.
Advertisement

Cellvax's expertise is based on its know-how in in vitro models,especially original in vivo models. These services can be offered to alllaboratories involving in anti-cancer drug development process. Theseproposed services adapt to the validation and development of anti-cancer drugcandidates and are fully validated such as sub-cutaneous and orthotopictumors models in animals; in vitro and in vivo angiogenesis models; anoriginal "Nodule" system, tumor invasion tests, in vivo imaging,bio-distribution, pharmacokinetics, toxicity, histological analysis,biomarker studies, ...

Cellvax is always ready to obey market evolution and to satisfy itscustomers' specific needs all over the world. In order to enhance itsdevelopment and continuously satisfy its customers, Cellvax has recentlymoved to a new laboratory facility, just on the border of Paris, inside"Ecole Nationale Veterinaire Alfort" (ENVA). The ENVA is one of the oldestand largest veterinary universities in Europe, created in 1766, with an easyaccess by subway. The ENVA is located on a large surface of 110 000 metressquared, with more than one thousand people (Scientists, Professors,technicians, students, ...) working here. In this new facility, Cellvax isable to provide to its customers a number of new services especially withdifferent species of animals (mice, rats, rabbits, dogs, minipigs, etc.),spontaneous naturally-developed tumors, in vivo imaging plat-forms, MRI,Scanner, Scintigraphy, histological analysis, biomarkers.

In summary, Cellvax is able to provide to its customers the services notonly in small animals, but also in large animals in a more efficient way.Contact Cellvax: Ming Wei, Ph.D. President & CEO Ecole Nationale Veterinaire Alfort Telephone: +33-(0)1-43-76-32-65; Mobile: +33-(0)6-71-43-47-51. E-mail: [email protected] Web Site: http://www.cellvax-pharma.com/

SOURCE CellVax
Sponsored Post and Backlink Submission


Latest Press Release on Research News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close